文献速递角膜与眼表疾病

新型地塞米松水凝胶递药系统在三维体外结膜炎症模型中对细胞因子和黏蛋白表达的影响

Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

研究建立三维体外结膜炎症模型,用TNF-α、IL-1β或二者联合诱导炎症,测试地塞米松水凝胶递药系统对细胞因子和黏蛋白表达的作用。结果显示联合刺激后多个细胞因子表达显著升高,地塞米松制剂显著降低IL6表达,黏蛋白表达在刺激后升高且经地塞米松制剂处理后进一步升高。该模型为干眼病药物体外测试提供新平台。

要点

  • 三维体外结膜炎症模型经TNF-α与IL-1β联合刺激后细胞因子表达显著增加。
  • 地塞米松制剂处理显著降低IL6表达。
  • 黏蛋白表达在炎症刺激后升高,地塞米松制剂处理后进一步升高。

核心结论

  • 建立了可分析新型治疗选项对细胞因子和黏蛋白表达影响的体外结膜炎症模型。
  • 该模型为干眼病药物体外测试提供新平台,并有助于深入研究炎症组织中结膜黏蛋白表达。

研究设计与样本

  • 将原代人结膜成纤维细胞嵌入压缩胶原基质,表面接种原代上皮细胞,气液界面培养15天。
  • 通过TNF-α、IL-1β或二者联合诱导炎症。
  • 应用原始地塞米松、基于聚(2-噁唑啉)的地塞米松胶束及负载地塞米松胶束的改性丙烯酸水凝胶验证疗效。

主要发现

  • TNF-α与IL-1β联合刺激后,所有测试细胞因子(IL1A、IL1B、IL6、IL8、MMP9)表达显著增加。
  • 地塞米松制剂处理显著降低IL6表达。
  • 黏蛋白表达在刺激后显著增加,地塞米松制剂处理后进一步升高。

关键数值与推荐

  • 细胞因子通过实时定量PCR和ELISA分析,黏蛋白通过实时定量PCR分析。

临床怎么用

  • 该三维体外结膜炎症模型可用于干眼病候选药物的体外疗效测试。
  • 地塞米松水凝胶递药系统在模型中显示降低IL6和升高黏蛋白表达的作用,需进一步体内验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Inflammation of the ocular surface is one of the key symptoms in dry eye disease (DED). Various eye drops are available to alleviate conjunctival inflammation but have limited effect and poor patient compliance. To facilitate testing of new treatments, we established a three-dimensional (3D) in vitro conjunctival inflammation model and tested a novel dexamethasone (Dex) hydrogel drug-delivery system on cytokine and mucin expression. METHODS: Primary human conjunctival fibroblasts were embedded in a compressed collagen matrix. Primary epithelial cells were seeded on top and cultured at the air-liquid-interface for 15 days. Inflammation was induced via TNF-α, IL-1β, or their combination. Pristine Dex, poly(2-oxazoline) (POx)-based Dex micelles and modified acrylic acid based hydrogel loaded with Dex micelles were applied to the inflammation model to verify the therapeutic efficacy. Pro-inflammatory cytokines were analyzed via real-time quantitative PCR (RT-qPCR) and ELISA. Conjunctival mucins were analyzed via RT-qPCR. RESULTS: The expression of all tested cytokines (IL1A, IL1B, IL6, IL8, MMP9) was significantly increased after combined stimulation with TNF-α and IL-1β. Treatment with Dex-formulations significantly reduced IL6 expression. The expression of mucins was significantly increased after stimulation and was further elevated after treatment with Dex-formulations. CONCLUSIONS: We established an inflammation model, in which the effects of novel treatment options on cytokine and mucin expression can be analyzed. This opens a new in vitro test platform for DED medication and enables deeper investigations into conjunctival mucin expression in inflamed tissue.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Schwebler J, Verma-Fuehring R, Kalantari N, et al. Effects of a Novel Dexamethasone Hydrogel Drug Delivery System on Cytokine and Mucin Expression in a Three-Dimensional In Vitro Conjunctival Inflammation Model. Invest Ophthalmol Vis Sci. 2026. PMID: 41556586. doi:10.1167/iovs.67.1.42

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。